The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
xin de ace yi zhi ji benazepril
Author(s): 
Pages: 245-246
Year: Issue:  4
Journal: World Clinical Drugs

Keyword:  仰卧位安慰剂临床试验轻度头痛和中;
Abstract: <正> 初步临床试验表明,benazepril是新的具有口服活性的有效的ACE抑制剂,且耐受性良好。30例轻度至中度特发性高血压(WHO1或2级)门诊患者(平均年龄51岁),先服2周安慰剂,仰卧位舒张血压≥95mmHg,接着服用本品20mg每日1次,连续2周,如果舒张压<95mmHg(标准),继续用原剂量治疗4周;如治疗2周后,舒张压仍≥95mmHg,则20mg每日2次,继续治疗4周。服用本品2周后,平均仰卧位和静息时血压显著降低(与治疗前对照),分别为148.3/87.5与163.9/100.7mmHg和148.9/
Related Articles
No related articles found